JPRN-UMIN000046338Completed未知
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer. - Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Sapporo Medical University
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Patients with active other cancers required to treat. 2) Patients with heart function failure (EF<60%). 3) Patients determined as being an inappropriate case by the investigators.
Investigators
Similar Trials
Recruiting
Not Applicable
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
Completed
Not Applicable
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48
Completed
Not Applicable
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Recruiting
Not Applicable
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30